|
Status |
Public on Jan 01, 2014 |
Title |
EOC P130 |
Sample type |
RNA |
|
|
Source name |
Ovarian tumor tissue
|
Organism |
Homo sapiens |
Characteristics |
excluded: no subclass: 2 age: 56 histology: Serous figo grade: IV grade: 3 peritoneal carcinomatosis: Yes residual tumor: Yes pfs event: 1 pfs month: 10 os event: 1 os month: 15
|
Extracted molecule |
total RNA |
Extraction protocol |
total RNA from epithelial ovarian cancer tissues was isolated with the ABI PRISM 6100 Nucleic Acid PrepStation (Applied Biosystems) according to the manufacturer’s instructions
|
Label |
DIG
|
Label protocol |
Applied Biosystems Chemiluminescent RT Labeling Kit
|
|
|
Hybridization protocol |
Applied Biosystems Chemiluminescence Detection Kit
|
Scan protocol |
Expression Array System Software v1.1.1
|
Description |
Human Genome Survey Microarray V2.0 (Applied Biosystems)
|
Data processing |
R Package ABarray 1.4.2 (Filtering flags > 5000, quantile normalization, log-2 transformation), Batch correction as follows: subtraction of the batch-specific mean from each gene, and add the overall mean.
|
|
|
Submission date |
Aug 19, 2013 |
Last update date |
Jan 01, 2014 |
Contact name |
Dietmar Pils |
E-mail(s) |
dietmar.pils@meduniwien.ac.at
|
Organization name |
Medical University of Vienna
|
Department |
Dept. of Surgery
|
Street address |
Waehringer Guertel 18-20
|
City |
Vienna |
ZIP/Postal code |
1090 |
Country |
Austria |
|
|
Platform ID |
GPL2986 |
Series (1) |
GSE49997 |
Validating the Impact of a Molecular Subtype in Epithelial Ovarian Cancer (EOC) on Progression Free and Overall Survival |
|